Entresto 97 MG-103 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F6QGD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,082
Award facts
- Contract value 100% obligated
- $10,081.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,081.75 to AmerSourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (60-count units) on January 7, 2026. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 8, 2026, with performance conducted at AmerSourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through full and open competition. This award represents a task order against AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as the primary mechanism for supplying pharmaceutical products and medical commodities to support military healthcare programs globally.
AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider. The company specializes in supplying a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to federal agencies, particularly the Department of Defense and Department of Veterans Affairs. Entresto, a prescription medication used for heart failure management, represents one of numerous pharmaceutical products the company regularly delivers under its federal contract portfolio, demonstrating its capability to efficiently fulfill essential medical supply requirements for military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F6QGD?
SPE2DR26F6QGD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F6QGD worth?
The government has obligated $10,082 on SPE2DR26F6QGD.
Is contract SPE2DR26F6QGD an order under another contract?
Yes. SPE2DR26F6QGD is a delivery order under SPE2DR25D3801, an indefinite delivery contract.
Was contract SPE2DR26F6QGD competed?
The extent of competition for SPE2DR26F6QGD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award